Results 261 to 270 of about 131,003 (284)

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Lancet, The, 2020
Jeff P Sharman, Miklos Egyed, Wojciech Jurczak   +2 more
exaly  

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Cell, 2022
Jana Biermann, Johannes C Melms, Amit Dipak Amin   +2 more
exaly  

Dynamic stem cell states: naive to primed pluripotency in rodents and humans

Nature Reviews Molecular Cell Biology, 2016
Muneef Ayyash, Jacob H Hanna
exaly  

The full spectrum of human naive T cells

Nature Reviews Immunology, 2018
Theo van den Broek, José A M Borghans
exaly  

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

Lancet, The, 2023
exaly  

Naive T cell homeostasis: from awareness of space to a sense of place

Nature Reviews Immunology, 2009
Stephen C Jameson
exaly  

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Lancet, The, 2011
Bonaventura Clotet, Kiat Ruxrungtham
exaly  

Naive Bayes

2009
openaire   +1 more source

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Lancet, The, 2019
Andrea Antinori, Chien-Ching Hung, Michael Aboud   +2 more
exaly  

Lazy MetaCost Naive Bayes

2007 International Conference on Convergence Information Technology (ICCIT 2007), 2007
Sotiris Kotsiantis, Dimitris Kanellopoulos   +1 more
openaire   +1 more source